Ad is loading...
JULCX
Price
$11.90
Change
-$0.02 (-0.17%)
Updated
Nov 15 closing price
PACAX
Price
$10.92
Change
-$0.06 (-0.55%)
Updated
Nov 15 closing price
Ad is loading...

JULCX vs PACAX

Header iconJULCX vs PACAX Comparison
Open Charts JULCX vs PACAXBanner chart's image
JHancock Multimanager Lifestyle Cnsrv R6
Price$11.90
Change-$0.02 (-0.17%)
VolumeN/A
CapitalizationN/A
Putnam Dynamic Asset Allocation Cnsrv A
Price$10.92
Change-$0.06 (-0.55%)
VolumeN/A
CapitalizationN/A
JULCX vs PACAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
JULCX vs. PACAX commentary
Nov 16, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JULCX is a Hold and PACAX is a StrongBuy.

FUNDAMENTALS
Fundamentals
JULCX has more cash in the bank: 1.65B vs. PACAX (576M). JULCX pays higher dividends than PACAX: JULCX (3.92) vs PACAX (2.18). JULCX was incepted earlier than PACAX: JULCX (13 years) vs PACAX (31 years). PACAX is a more actively managed with annual turnover of: 456.00 vs. JULCX (15.00). PACAX has a lower initial minimum investment than JULCX: PACAX (0) vs JULCX (1000000). PACAX annual gain was more profitable for investors over the last year : 16.76 vs. JULCX (12.08). PACAX return over 5 years is better than : 11.40 vs. JULCX (8.90).
JULCXPACAXJULCX / PACAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence13 years31 years-
Gain YTD6.46210.12364%
Front LoadN/AN/A-
Min. Initial Investment10000000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.65B576M287%
Annual Yield % from dividends3.922.18180%
Returns for 1 year12.0816.7672%
Returns for 3 years-3.41-2.74124%
Returns for 5 years8.9011.4078%
Returns for 10 years17.7315.39115%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GPGCX16.980.11
+0.65%
Grandeur Peak Global Contrarian Instl
JHLVX62.38N/A
N/A
JHancock Fundamental Large Cap Core C
FIUSX38.16N/A
N/A
Delaware Opportunity A
NSFEX11.43-0.04
-0.35%
Natixis Target Retirement 2025 N
ETNHX34.80-0.82
-2.30%
Eventide Healthcare & Life Sciences N